GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **3101 - 3125** of **4050** in total

« First

‹ Prev

…

121

122

123

124

125

126

127

128

129

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgG	Patient 2	15	mild	G18057VI	343
IgG	Patient 2	24	mild	G18057VI	271
IgM	Patient 2	15	mild	G18057VI	118
IgM	Patient 2	24	mild	G18057VI	124
IgM	Patient 1	6	moderate	G18057VI	41
IgA	Patient 2	3	mild	G18057VI	356
IgG	Patient 2	3	mild	G18057VI	601
IgM	Patient 2	3	mild	G18057VI	181
IgA	Patient 3	-180	mild	G18057VI	260
IgA	Patient 3	11	mild	G18057VI	459
IgG	Patient 3	-180	mild	G18057VI	54
IgM	Patient 3	-180	mild	G18057VI	95
IgA	Patient 3	4	mild	G18057VI	449
IgG	Patient 3	11	mild	G18057VI	45
IgG	Patient 3	4	mild	G18057VI	44
IgM	Patient 3	11	mild	G18057VI	106
IgM	Patient 3	4	mild	G18057VI	94
IgA	Patient 4	12	mild	G18057VI	387
IgG	Patient 4	12	mild	G18057VI	100
IgM	Patient 4	12	mild	G18057VI	157
IgA	Patient 1	10	moderate	G17689EW	414
IgA	Patient 1	22	moderate	G17689EW	772
IgA	Patient 1	6	moderate	G17689EW	409
IgG	Patient 1	10	moderate	G17689EW	106
IgG	Patient 1	22	moderate	G17689EW	114